Feds Rip PhRMA's Free Speech Claims In FCA Off-Label Suit
The U.S. Department of Justice is urging a California federal judge to reject free speech arguments advanced in a False Claims Act case by Pharmaceutical Research and Manufacturers of America, adding...To view the full article, register now.
Already a subscriber? Click here to view full article